Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) announced a dividend on Monday, March 10th, NASDAQ Dividends reports. Stockholders of record on Monday, April 7th will be given a dividend of 0.3758 per share by the biotechnology company on Wednesday, April 23rd. The ex-dividend date of this dividend is Monday, April 7th. This is a 123.9% increase from Novozymes A/S’s previous dividend of $0.17.
Novozymes A/S Stock Up 1.1 %
OTCMKTS NVZMY opened at $58.96 on Wednesday. The company has a market cap of $27.61 billion, a price-to-earnings ratio of 37.32, a P/E/G ratio of 3.87 and a beta of 0.91. Novozymes A/S has a 52 week low of $52.96 and a 52 week high of $72.50. The business has a 50 day moving average price of $57.09 and a 200-day moving average price of $61.27.
Wall Street Analysts Forecast Growth
Separately, Barclays upgraded Novozymes A/S to a “strong-buy” rating in a report on Monday, November 18th.
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Companies Buying Back Stock—Why It Matters
- What Are the U.K. Market Holidays? How to Invest and Trade
- Institutions Bought 3 Stocks Heavily in Q1 2025
- Stock Market Sectors: What Are They and How Many Are There?
- Beyond a Market Correction, Moves to Make Now
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.